Beam Therapeutics Inc. · NASDAQ:BEAM
Simon Amy sold 373 Beam Therapeutics Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Simon Amy (Chief Medical Officer) sold 373 Beam Therapeutics Inc. shares at US$34.73 for US$12,954 under a trading plan, leaving 102,363 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 373 shares
- Price
- US$34.73
- Value
- US$12,954
- Holding after
- 102,363 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Sale | 373 | US$34.73 | 102,363 | Direct |
Source
Related
- Beam Therapeutics Inc.
- Simon Amy
- Beam Therapeutics Inc. shareholders
- Form 4 · Simon Amy · Jul 29, 2026
- Form 4 · Simon Amy · Apr 6, 2026
- Form 4 · Simon Amy · Apr 2, 2026
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026